Valeo Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.41M Sell
3,623
-493
-12% -$192K 0.03% 218
2025
Q1
$1.79M Buy
4,116
+1,029
+33% +$448K 0.05% 176
2024
Q4
$1.14M Sell
3,087
-886
-22% -$327K 0.03% 232
2024
Q3
$2.07M Sell
3,973
-717
-15% -$373K 0.06% 150
2024
Q2
$2.54M Sell
4,690
-145
-3% -$78.6K 0.08% 124
2024
Q1
$2.58M Sell
4,835
-240
-5% -$128K 0.09% 117
2023
Q4
$2.39M Buy
5,075
+1
+0% +$472 0.1% 118
2023
Q3
$2.21M Sell
5,074
-294
-5% -$128K 0.1% 114
2023
Q2
$2.38M Buy
5,368
+189
+4% +$84K 0.11% 107
2023
Q1
$2.38M Sell
5,179
-1,136
-18% -$522K 0.11% 111
2022
Q4
$3.24M Buy
6,315
+721
+13% +$370K 0.18% 75
2022
Q3
$2.54M Buy
5,594
+1,110
+25% +$504K 0.16% 85
2022
Q2
$2.16M Sell
4,484
-122
-3% -$58.9K 0.14% 91
2022
Q1
$2.26M Buy
4,606
+48
+1% +$23.6K 0.12% 106
2021
Q4
$2.11M Sell
4,558
-134
-3% -$62.1K 0.11% 102
2021
Q3
$1.75M Buy
4,692
+242
+5% +$90.2K 0.1% 119
2021
Q2
$1.7M Sell
4,450
-24
-0.5% -$9.16K 0.1% 115
2021
Q1
$1.61M Sell
4,474
-210
-4% -$75.4K 0.07% 136
2020
Q4
$1.5M Sell
4,684
-95
-2% -$30.5K 0.08% 127
2020
Q3
$1.28M Sell
4,779
-208
-4% -$55.9K 0.11% 111
2020
Q2
$1.31M Sell
4,987
-1,001
-17% -$263K 0.12% 106
2020
Q1
$1.45M Buy
5,988
+362
+6% +$87.8K 0.15% 92
2019
Q4
$1.7M Buy
5,626
+1,330
+31% +$402K 0.16% 90
2019
Q3
$1.03M Buy
4,296
+132
+3% +$31.7K 0.11% 122
2019
Q2
$1.18M Sell
4,164
-25
-0.6% -$7.06K 0.13% 114
2019
Q1
$1.2M Sell
4,189
-602
-13% -$173K 0.15% 107
2018
Q4
$1.26M Buy
4,791
+1,108
+30% +$291K 0.18% 94
2018
Q3
$1.01M Buy
3,683
+269
+8% +$74K 0.14% 115
2018
Q2
$897K Sell
3,414
-115
-3% -$30.2K 0.13% 122
2018
Q1
$775K Sell
3,529
-821
-19% -$180K 0.12% 118
2017
Q4
$979K Buy
4,350
+4
+0.1% +$900 0.16% 101
2017
Q3
$825K Buy
+4,346
New +$825K 0.19% 97